– USA, CO – DaVita Inc. (NYSE: DVA), today announced the appointment of Dennis Pullin to its Board as an Independent director effective April 10, 2024, bringing the Board to 11 members.
“We’re pleased to welcome Dennis to DaVita’s board,” said Pamela Arway, independent chair of the DaVita Inc. Board of Directors. “Given his depth of experience within the healthcare system, we’re excited about the perspective Dennis will bring to the Board and look forward to his positive impact on our future growth and performance.”
Dennis Pullin will join the Compliance and Quality Committee.
About Dennis Pullin
Dennis Pullin is a recognized thought leader and advocate for health equity with more than 30 years of experience in executive leadership positions in hospitals, academic medical centers, physician group practices, and private industry. He currently serves as president and CEO of Virtua Health, a $2 billion non-profit academic health system in New Jersey with more than 400 care locations. Before joining Virtua in 2017, Dennis Pullin was president of MedStar Harbor Hospital and SVP of MedStar Health. He has also served as SVP and COO of MedStar Washington Hospital Center in Washington, D.C.; VP of operations and business development at St. Luke’s Episcopal Health System in Houston; and VP of acquisitions and development at Symbion Healthcare.
“As someone who has dedicated my professional endeavors to healthcare and serving communities, I’ve long-admired DaVita’s commitment to improving health outcomes for some of the most complex patient populations,” said Dennis Pullin. “It’s an honor to join the Board, and I look forward to playing a role in the continued transformation of kidney care delivery.”
About DaVita Inc.
DaVita is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The company is one of the largest providers of kidney care services in the U.S. and has been a leader in clinical quality and innovation for more than 20 years. DaVita cares for patients at every stage and setting along their kidney health journey—from slowing the progression of kidney disease to helping to support transplantation, from acute hospital care to dialysis at home. As of December 31, 2023, DaVita served approximately 250,200 patients at 3,042 outpatient dialysis centers, of which 2,675 centers were located in the United States and 367 centers were located in 11 other countries worldwide. DaVita has reduced hospitalizations, improved mortality, and worked collaboratively to propel the kidney care industry to adopt an equitable and high-quality standard of care for all patients, everywhere.
SOURCE: https://www.davita.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
